Chemiluminescence Immunology Analyzer and Reagent

  • Year Founded: 2007
  • Headquarters: Beijing,China
  • Estimated Employees: N/A
  • Product Lines:
    • Immunodiagnostic
    • Clinical Chemistry
  • Products:
    • LiCA 500/800 Chemiluminescence Immunology Analyzer
    • CC 1500 Chemiluminescence Immunology Analyzer
Kemei LiCA 500 Chemiluminescence Immunology Analyzer

LiCA 500 Chemiluminescence Immunology Analyzer

Kemei LiCA 800 Chemiluminescence Immunology Analyzer

LiCA 800 Chemiluminescence Immunology Analyzer

Kemei CC 1500 Chemiluminescence Immunology Analyzer

Kemei CC 1500 Chemiluminescence Immunology Analyzer

Chemclin Diagnostics Co., LTD (hereinafter it was referred to as Chemclin Diagnostics), founded in 2007, is one of the pioneers in developing clinical immunoassays and systems in China. Chemclin Diagnostics is specialized in the research and development, production, sales and service of In Vitro Diagnostics (IVD) products.

Currently, chemiluminescence immunology is the core business of Chemclin Diagnostics. In terms of technology, from the product development of radioimmunoassay and enzymatic chemiluminescence immunoassay to the cross-generation technology platform of Light-initiated Chemiluminescence Immunoassay(LiCA). Chemclin’s R&D team has accumulated rich experiences in the product development on assays and automated systems.

Among them, LiCA is a leading immunoassay technology platform in both China and overseas. LiCA is a unique technology with the integration of varies of cutting edge technologies. Such as, nanoparticle polymers, light-initiated chemiluminescent signaling technology, wash-free immunoassay technology and the corresponding automation technologies. LiCA is developed by a technical team led by Professor Zhao Wei Guo, a senior overseas scholar and Chief Technology Officer (CTO), with years of efforts.

At present, Chemclin Diagnostics has successfully developed assays for multiple disease panels and series of automated LiCA systems.